Related Experiment Video
Updated: Aug 28, 2025

09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
11.4K
Macroporous dextran hydrogels for controlled growth factor capture and delivery using coiled-coil interactions.
Romane Oliverio1, Victor Patenaude2, Benoît Liberelle2
1Department of Chemical Engineering, Polytechnique Montréal, Montréal, Québec H3T 1J4, Canada; Faculty of Pharmacy, Axe Formulation et Analyse du Médicament (AFAM), Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Acta Biomaterialia
|September 16, 2022
Summary
This study developed tunable macroporous dextran hydrogels for controlled growth factor delivery. Affinity peptides enable efficient capture and sustained release, advancing biomedical applications.
Area of Science:
- Biomaterials Science
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Macroporous hydrogels offer potential in biomedicine but lack controlled biomolecule capture and release due to large pores.
- Existing hydrogel systems struggle with efficient, sustained, and controlled delivery of therapeutic biomolecules.
- There is a need for biofunctionalized, affinity-based hydrogels for precise biomolecule loading and release.
Purpose of the Study:
- To develop a tunable platform for controlled capture and sustained delivery of growth factors using macroporous dextran hydrogels.
- To utilize a coiled-coil affinity pair (E/K) for biofunctionalizing hydrogels and enabling controlled biomolecule interactions.
- To investigate the impact of key parameters on growth factor loading and release kinetics.
Main Methods:
- Conjugation of Kcoil peptide to dextran backbone of macroporous hydrogels.
- Loading of Ecoil-tagged Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor (VEGF).
- Systematic variation of macropore size, Kcoil grafting density, Ecoil valency, and E/K affinity to tune performance.
Main Results:
- Kcoil grafting increased passive growth factor capture by 20-fold compared to unmodified gels.
- Gels demonstrated sustained release, with only 20% of loaded growth factors released over one week.
- Loaded growth factors retained their bioactivity after capture and release from the hydrogel system.
Conclusions:
- A versatile and highly tunable platform for controlled growth factor delivery was successfully developed.
- The affinity-based approach enables passive loading and sustained release, suitable for in situ applications.
- These macroporous dextran hydrogels show significant promise for tissue engineering and regenerative medicine.

